Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-04-13, PDS Biotechnology Corporation (PDSB) trades at a current price of $1.09, marking a 0.93% gain in the latest trading session. This analysis outlines key technical levels, recent market context, and potential near-term scenarios for the clinical-stage biotech firm, which operates in the fast-moving healthcare segment focused on immuno-oncology product development. No recent earnings data is available for PDSB as of this analysis, so recent price action has been driven primarily b
Is PDS (PDSB) Stock Expanding | Price at $1.09, Up 0.93% - Top Breakouts
PDSB - Stock Analysis
3328 Comments
564 Likes
1
Shandria
Elite Member
2 hours ago
This would’ve saved me from a bad call.
👍 54
Reply
2
Ariyan
New Visitor
5 hours ago
As someone busy with work, I just missed it.
👍 239
Reply
3
Julaine
Returning User
1 day ago
Are you secretly a superhero? 🦸♂️
👍 295
Reply
4
Sethe
Expert Member
1 day ago
This would’ve saved me from a bad call.
👍 259
Reply
5
Baqir
Active Reader
2 days ago
This sets a high standard.
👍 279
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.